---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-001113"
form_type: "8-K"
ticker: "NRXP"
cik: "0001719406"
company_name: "NRX Pharmaceuticals, Inc."
filed_at: "2025-01-14T23:59:59+00:00"
generated_at: "2026-05-28T02:07:27.508592+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# NRx Pharma board member Janet Rehnquist resigns; JGS Holdings gets board designation right

## Summary
- Janet Rehnquist resigned from the Board effective January 7, 2025; no disagreement with Company.
- Term sheet with JGS Holdings LLC (Sauer Nunes) grants right to designate a Board member.
- Management currently considering nominees from JGS Holdings for appointment to the Board.

## SEC filing metadata
- accession: 0001437749-25-001113
- form_type: 8-K
- ticker: NRXP
- cik: 0001719406
- company_name: NRX Pharmaceuticals, Inc.
- filed_at: 2025-01-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1719406/000143774925001113/0001437749-25-001113-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1719406/000143774925001113/nrxp20250114_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-001113
- JSON: https://secwatch.observer/filing/0001437749-25-001113.json
- Plain text: https://secwatch.observer/filing/0001437749-25-001113.txt

## Key facts
- Executive change
  Janet Rehnquist resigned as member of the Board of Directors at NRX Pharmaceuticals, Inc..
  - Action: resigned
  - Role: member of the Board of Directors
  source text: On January 7, 2025, Janet Rehnquist resigned as a member of the Board of Directors (“ Board ”) of NRx Pharmaceuticals, Inc. (the “ Company ”), effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1719406/000143774925001113/0001437749-25-001113-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.